The Case for Small-Cap Value: Decades of Evidence, Years of Pain

Why I Like Small-Cap Value

I like small-cap value not because I think it is magic, but because it is one of the rare tilts with decades of evidence, a plausible economic story, and enough discomfort attached to it that many investors abandon it at exactly the wrong time. The premium exists in the data. It shows up internationally. And it remains hard to hold in practice because the ride is psychologically brutal.

This guide covers what small-cap value actually is, what the data say, why the premium might persist, and what can go wrong. Every claim here is backed by academic research or institutional data. Small-cap value is not guaranteed. It is an expected-return argument, and that distinction matters.

What Small-Cap Value Actually Is

Small-cap value refers to stocks of smaller companies trading at low prices relative to their fundamentals: book value, earnings, or cash flow. In the Fama-French framework, these are companies in the bottom half of market capitalization (small) and the top third of book-to-market ratio (value).

The combination matters. Small-cap stocks alone have a complicated track record. Value stocks alone have a strong record. But the intersection of small and value has historically produced the highest expected returns of any equity style box.

What the Data Say

The Long-Run Premium

From June 1927 to May 2023, Dimensional's U.S. small-cap value index returned approximately 13.1% annualized versus the S&P 500 at 10.1%. That 3 percentage point gap, compounded over decades, is enormous. A dollar invested in small-cap value in 1927 would be worth roughly 10 times what the same dollar in the S&P 500 would be worth.

The Academic Foundation

The evidence starts with Banz (1981), who found that smaller firms had higher average risk-adjusted returns than larger firms, evidence that the Capital Asset Pricing Model was missing something. Fama and French (1992) then showed that size and book-to-market together explain much of the cross-sectional variation in stock returns, and in 1993 they formalized SMB (Small Minus Big) and HML (High Minus Low) as core factors.

It Works Internationally

In their international work, Fama and French found value premiums across North America, Europe, Japan, and Asia Pacific. Critically, except for Japan, value premiums were larger for small stocks. That interaction effect is one of the cleanest pieces of evidence for why small-cap value specifically, not just "value" or "small" alone, deserves attention.

The Sample Period Problem

Data from Dimensional Fund Advisors. Exact SCV figures vary by index definition. The 2010-2024 period illustrates that premiums can disappear for extended stretches.

The last column is the uncomfortable part. From 2010 to 2024, the S&P 500 crushed small-cap value. Anyone who started their SCV tilt in 2010 has spent 15 years underperforming. That is not a bug; it is the price of admission. The premium existsbecause it is painful to hold.

Why the Premium Might Exist

There are two explanations, and they are not mutually exclusive.

The Risk Explanation

Fama and French's framework treats size and value as characteristics associated with differences in expected returns. Their five-factor model ties expected returns to valuation, profitability, and investment: given expectations about cash flows, firms with lower prices relative to fundamentals should have higher expected returns. Small, cheap firms are often more fragile businesses with less financial flexibility and a wider range of outcomes. Investors may require a higher expected return to hold them.

The Behavioral Explanation

Lakonishok, Shleifer, and Vishny (1994) argued that value strategies earn higher returns because investors systematically extrapolate past growth too far into the future, overpay for glamorous growth companies, and underprice neglected, unpopular firms. Small-cap value sits right in the sweet spot of that story: companies that are both small and cheap are exactly the kinds of stocks most investors ignore or dislike.

The combined framing: small-cap value may work because these stocks are both riskier to own and easier for markets to misprice. The risk story explains why the premium should exist in theory. The behavioral story explains why it persists in practice, even after being widely published.

Why Small-Cap Value, Not Just "Small Caps"

The raw size effect has legitimate criticisms. Even AQR's "Size Matters, If You Control Your Junk" acknowledges weak post-discovery performance, concentration in microcaps, January seasonality, and overlap with illiquidity. Their key finding: once you control for quality/junk, a more stable size premium emerges.

This actually strengthens the case for small-cap value done thoughtfully. The best version is not "buy the tiniest, ugliest, statistically cheapest names." It is closer to: tilt toward smaller, cheaper companies while avoiding the worst balance sheets, weakest profitability, and most illiquid junk. That framing is consistent with both the AQR evidence and with how Avantis, Dimensional, and Alpha Architect design their funds today.

How to Access It

AVUV and DFSV are the most popular choices for U.S. small-cap value. Both screen for profitability, which addresses the "junk" problem. AVDV and DISV extend the same approach internationally. VBR is the cheapest option but has weaker factor exposure (it holds more "blend" stocks that are not clearly value).

For a full factor decomposition of how much SCV exposure your portfolio actually has, Summitward's portfolio analysis runs a Carhart 4-factor regression showing your SMB (size) and HML (value) loadings.

What Could Go Wrong

Small-cap value is an expected-return argument, not a promise. Dimensional's research shows that positive size, value, and profitability premiums are expected but volatile. Realized premiums can be negative over rolling one-, five-, and even ten-year periods. The odds improve with longer holding periods, but the premium is not guaranteed on any investor's schedule.

• Decade-long droughts. From 2010 to 2024, U.S. large-cap growth dominated and SCV trailed. Fifteen years is a long time to underperform. Many investors abandoned the tilt during this period.
• Higher volatility. Avantis notes that small- and mid-cap stocks have historically been more volatile than large-cap stocks. Smaller companies have more limited resources and trade less frequently, increasing both price swings and trading costs.
• The five-factor complication. In the Fama-French five-factor model, the traditional value factor HML becomes "redundant" once profitability and investment are added. This does not mean value stopped mattering. It means part of what looked like "value" may also be capturing profitability effects. Modern SCV funds (AVUV, DFSV) incorporate this insight.
• Tracking error is painful. When the S&P 500 returns 20% and your SCV tilt returns 8%, the 12 percentage point gap feels like a mistake. It is not. It is the cost of holding a strategy with higher expected returns but different return patterns.

The Right Framing

Small-cap value is not free money. It is a disciplined bet on an unpopular corner of the market with a better long-run expected return. The premium exists because it is painful. If it were easy to hold, everyone would hold it, and the premium would be arbitraged away.

The question is not "will small-cap value outperform over the next 5 years?" Nobody knows. The question is "am I willing to accept decade-long underperformance in exchange for higher expected returns over a 20-30 year horizon?" If the answer is yes, and you can actually hold through the drought, the evidence is on your side.

Frequently Asked Questions

What is small-cap value?

Stocks of smaller companies trading at low prices relative to their fundamentals (book value, earnings, cash flow). In the Fama-French framework, these are companies in the bottom half of market capitalization and the top third of book-to-market ratio.

Has small-cap value outperformed the S&P 500?

Over the long run, yes. From 1927 to 2023, U.S. small-cap value returned approximately 13.1% annualized versus 10.1% for the S&P 500 (Dimensional data). However, there have been extended periods (2010-2024) where the S&P 500 significantly outperformed.

Why does the small-cap value premium exist?

Two explanations: (1) Risk: smaller, cheaper companies are more fragile and investors require higher returns to hold them (Fama-French). (2) Behavioral: investors overpay for glamorous growth stocks and underprice neglected, unpopular firms (Lakonishok, Shleifer, Vishny 1994). Both likely contribute.

What is the best small-cap value ETF?

AVUV (Avantis) and DFSV (Dimensional) are the most popular for U.S. SCV. Both screen for profitability to avoid "junk." VBR (Vanguard) is the cheapest but has weaker factor exposure. For international SCV, AVDV and DISV are the leading options.

Is small-cap value risky?

Yes. Smaller stocks are more volatile, less liquid, and more sensitive to economic downturns. The premium is compensation for this risk. It is not a free lunch. Decade-long underperformance is a documented feature, not a bug.

Should I put my entire portfolio in small-cap value?

No. SCV is a tilt, not a replacement for broad market exposure. Most evidence-based investors use it as a portfolio overweight (10-30% allocation) alongside total market funds like VTI and VXUS. Concentration in any single factor increases tracking error and drawdown risk.

Key Takeaways

• Small-cap value has outperformed the S&P 500 by ~3% annually since 1927. The premium is strongest when value is paired with small size, and it shows up internationally.
• The premium is compensation for pain. Business risk, unpopularity, and 10-15 year periods of underperformance are the price of admission. If it were easy, the premium would not exist.
• Implementation matters. Modern SCV funds (AVUV, DFSV) screen for profitability to avoid the "junk" problem identified by AQR. Cheap and small alone is not enough.
• The 2010-2024 drought was real. SCV trailed large-cap growth for 15 years. This is within the historical range of expected underperformance, not evidence that the premium has disappeared.
• SCV is a tilt, not a portfolio. Use it as a 10-30% overweight alongside broad market exposure, not as a standalone allocation.

Related Guides

• If Dimensional Gets Sold, Should Factor Investors Care? — fund-sponsor and strategy-drift risk, and the tax cost of holding small-cap-value ETFs like DFSV in a taxable account.
• RMW Explained: The Profitability Factor — the profitability dimension of small-cap-value funds in depth: the Novy-Marx framing, out-of-sample evidence, and how Avantis vs Dimensional define profitability differently.
• Why I Like AVUV, AVDV, and AVGV — the follow-up guide on how to implement SCV through specific funds
• Fama-French Factor Analysis — the complete framework behind SMB, HML, and the five-factor model
• The Case for Global Equity Diversification — why SCV internationally (AVDV, DISV, AVES) matters as much as domestic
• Growth Stocks vs. Systematic Momentum — how SCV relates to other factor strategies
• Dividends Are Not Free Money — why targeting factors directly beats screening for dividends